Multi-ingredient Supplement for Strength and Power

February 1, 2016 updated by: Florida State University

The Impact of T+ Supplementation on Anabolic Hormone Profile and Performance in Power Athletes

It has been suggested that high amounts of total serum testosterone levels correlate with higher lean body mass, lowered fat mass, greater muscle strength, and faster recovery. These suggestions drive athletes and body builders to find ways to raise their testosterone levels. Many athletes and bodybuilders look to alternative methods to anabolic steroids in order increase their testosterone levels without legal repercussions or physiological side effects. Herbs and other plant extracts have been introduced as a possible source to naturally boost testosterone levels. Research supporting the use of herbs and plant extracts has been shown to be equivocal. However, evidence in studies with hypogonadal men suggests that longjack root may naturally boost testosterone levels.

Onnit Labs, LLC has packaged this supplement (T+) which claims it can naturally boost testosterone and lower estrogen levels and subsequently improve performance. This product is a powder (11g) that is mixed with 16 oz of water and consumed 20 minutes prior to anaerobic workouts, such as high intensity weight training.

T+ is a multi-ingredient supplement that consists of vitamins B5 and B6, magnesium aspartic acid, mucuna pruriens, longjack root, nettle root, red clover luteolin, resveratrol, beta- alanine, branch chain amino acids, L- glutamine, Bioperine, and Fibersol 2.

The active ingredients purported to boost plasma testosterone levels are mucuna pruriens, longjack root, and magnesium aspartic acid. The active ingredients claimed to lower plasma estrogen concentrations are red clover, luteolin, resveratrol and nettle root. All other ingredients (Branch Chain Amino Acids and Beta-Alanine) have been documented to improve exercise performance.

It is hypothesized that there will not be any physiological changes after supplementation of T+. It is also hypothesized that performance will not be affected by the supplementation of T+.

Study Overview

Status

Completed

Conditions

Detailed Description

The purpose of this study is to examine the physiological and performance effects of T+ on power athletes.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tallahassee, Florida, United States, 32306
        • Florida State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Must be familiar with the three main powerlifting movements (squat, bench and deadlift)
  • Must have one month training with a designated strength coach to understand the expectations of the strength coach and movement patterns for performance
  • Have no pre-existing musculoskeletal disorders
  • Participate in the three-week supplement wash out prior to beginning the experiment (except for basic protein supplements and multivitamins)

Exclusion Criteria:

  • Female

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: T+ Supplement
This arm requires the participants to take a prescribed dose of the T+ supplement for 4 weeks while completing an exercise regiment.
Randomized, placebo-controlled, double blind protocol with two treatment groups (matched by lean body mass). Group 1 will receive the recommended serving of one scoop (11g) of T+ supplement. This serving will be taken 45 minutes before the beginning of working out on an empty stomach (>1 hour after meal). On non-training days, the participants will also take a serving at the same time as on training days. This will continue for four weeks (28 days).
Placebo Comparator: Placebo
This arm requires the participants to take a prescribed dose of a calorie matched placebo for 4 weeks while completing an exercise regiment.
The placebo group will consume a calorie-match placebo in the same manner as the supplement group (one serving 45 minutes prior to work outs on an empty stomach). The placebo group will also follow the same supplementation patterns and workout as their counterparts in the supplement group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength Performance Outcomes
Time Frame: Baseline measures and 4 weeks from start of study

Measurement of one repetition maximums strength for all competition lifts included in a standard, ungeared, powerlifting competition (squat, bench, and deadlift). This testing will take place before the supplementation of either T+ or placebo and at the end of the four-week training period.

Each measure was only compared within it's own category against the baseline measurement and against that of the other group at the same time point.

Baseline measures and 4 weeks from start of study
Insulin Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Measurements of insulin will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
Baseline, 2-week mark, 4-week mark
Blood Lipid Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Measurements for blood lipid panels will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
Baseline, 2-week mark, 4-week mark
Total Testosterone Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Measurements for testosterone will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
Baseline, 2-week mark, 4-week mark
Estrogen Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Measurements for estrogen will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
Baseline, 2-week mark, 4-week mark
Insulin-like Growth Factor-I Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Measurements for insulin-like growth factor-I will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
Baseline, 2-week mark, 4-week mark
Bio-availableTestosterone Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Measurements for total testosterone will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
Baseline, 2-week mark, 4-week mark
Free Testosterone Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Measurements for free testosterone will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
Baseline, 2-week mark, 4-week mark
Dihydrotestosterone Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Measurements for dihydrotestosterone (DHT) will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
Baseline, 2-week mark, 4-week mark
Cortisol Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Baseline, 2-week mark, 4-week mark
Sex-hormone Binding Globulin Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Baseline, 2-week mark, 4-week mark
Creatine-Kinase Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
Baseline, 2-week mark, 4-week mark

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Volume Performance Outcomes
Time Frame: 4 Weeks
During the four weeks, the volume ((weight x reps)set 1+(weight x reps)set 2+ (weight x reps)set 3….. ) will be calculated and measured for each exercise in each lifting session.
4 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Michael J Ormsbee, PhD, Florida State University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

August 27, 2013

First Submitted That Met QC Criteria

October 24, 2013

First Posted (Estimate)

October 29, 2013

Study Record Updates

Last Update Posted (Estimate)

February 29, 2016

Last Update Submitted That Met QC Criteria

February 1, 2016

Last Verified

February 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • HSC#: 2013.10364

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Supplement

Clinical Trials on T+ Supplement

3
Subscribe